Fair Value Upside
Undervalued Stocks – Page 27
Fundamentally validated companies trading below PriceToWorth Primary Fair Value, ranked by business quality, growth, risk and large-cap or major-index credibility.
Showing 625–648 of 1,879 stocks
Page 27 of 79
Data as of
Oct 24, 2026
Criteria
At least 10% upside to PriceToWorth Primary Fair Value, Medium-or-better Primary Fair Value confidence, fundamental evidence, common equity and $100M+ market cap by default.
Ranking
Primary-Fair-Value hybrid: bounded upside, Primary Fair Value confidence, financial health, cash conversion, growth, sector-aware multiples, balance-sheet risk and Large-Cap / major-index credibility. Analyst data and component valuation models do not affect this ranking.
Data quality
Validated results require usable primary evidence and apply sector-appropriate quality checks; unavailable supporting metrics remain neutral rather than becoming zero.
Strong favorable
Favorable
Watch
Risk / negative
Neutral
↔ Scroll horizontally to compare all relevant metrics Swipe horizontally to compare all relevant metrics
Rank
Ticker
Market
Fair Value Gap
Analyst Upside
P/E
P/B
P/S
Dividend Yield
Health
Market Cap
#625
IPI
NYSE
18.3% Upside
Undervalued
16.9% Upside
26.4x
0.8x
1.7x
—
Great
$412.90M
#626
ESOA
NASDAQ
17.6% Upside
Fair
170.0% Upside
16.5x
2.1x
0.4x
1.7%
Good
$172.80M
#627
CCL
NYSE
15.4% Upside
Fair
29.8% Upside
11.2x
2.5x
1.3x
2.3%
Great
$35.11B
#628
DOCU
NASDAQ
14.4% Upside
Fair
-17.5% Downside
48.3x
9.3x
4.7x
—
Great
$15.94B
#629
BFST
NASDAQ
13.1% Upside
Fair
9.7% Upside
11.8x
1.1x
3.1x
1.9%
Good
$1.04B
#630
CPAY
NYSE
11.6% Upside
Fair
12.7% Upside
23.7x
7.6x
5.3x
—
Good
$26.82B
#631
SMCI
NASDAQ
49.8% Upside
Undervalued
31.3% Upside
9.9x
2.1x
0.6x
—
Good
$21.64B
#632
CHWY
NYSE
40.4% Upside
Undervalued
30.6% Upside
32.2x
23.8x
0.7x
—
Good
$8.81B
#633
ENPH
NASDAQ
38.2% Upside
Undervalued
55.5% Upside
31.2x
3.5x
3.1x
—
Fair
$4.18B
#634
PRTA
NASDAQ
34.1% Upside
Undervalued
161.0% Upside
—
1.5x
7.7x
—
Good
$421.00M
#635
AXS_PE
NYSE
33.5% Upside
Undervalued
—
7.0x
1.3x
1.1x
7.9%
Great
$7.49B
#636
PCRX
NASDAQ
30.3% Upside
Undervalued
-7.8% Downside
99.2x
2.2x
1.9x
—
Great
$1.45B
#637
PMTS
NASDAQ
26.9% Upside
Undervalued
20.9% Upside
22.7x
—
0.5x
—
Good
$311.70M
#638
AMH_PG
NYSE
26.0% Upside
Undervalued
—
24.8x
1.9x
7.0x
7.2%
Good
$13.09B
#639
AMH_PH
NYSE
24.0% Upside
Undervalued
—
24.8x
1.9x
7.0x
7.2%
Good
$13.09B
#640
PFIS
NASDAQ
22.7% Upside
Undervalued
4.0% Upside
12.5x
1.3x
3.7x
3.5%
Good
$707.50M
#641
VEON
NASDAQ
21.1% Upside
Undervalued
8.4% Upside
96.9x
3.8x
1.2x
—
Great
$5.72B
#642
KEY_PI
NYSE
20.9% Upside
Undervalued
—
11.3x
1.4x
2.9x
6.1%
Fair
$22.31B
#643
KVYO
NYSE
20.2% Upside
Undervalued
24.3% Upside
885.1x
6.2x
4.3x
—
Good
$6.01B
#644
T
NYSE
18.5% Upside
Undervalued
32.8% Upside
10.8x
1.3x
1.1x
5.3%
Fair
$141.00B
#645
CLBT
NASDAQ
18.3% Upside
Undervalued
26.9% Upside
52.1x
5.6x
5.9x
—
Great
$3.04B
#646
BML_PH
NYSE
17.8% Upside
Fair
—
11.4x
1.3x
3.0x
6.6%
Good
$350.00B
#647
FNF
NYSE
16.3% Upside
Fair
33.5% Upside
14.0x
1.5x
0.7x
5.1%
Good
$10.85B
#648
JBS
NYSE
16.3% Upside
Fair
49.0% Upside
11.9x
1.6x
0.1x
8.1%
Good
$13.30B
No company or ticker on this page matches your search.